Ligand substitutions between ruthenium-cymene compounds can control protein versus DNA targeting and anticancer activity

• Main Authors: Adhireksan, Z., Davey, G.E., Campomanes, P., Groessl, M., Clavel, C.M., Yu, H., Nazarov, A.A., Yeo, C.H.F., Ang, W.H., Dröge, P., Rothlisberger, U., Dyson, P.J., Davey, C.A.
• Other Authors: CHEMISTRY
• Format: Article
• Published: 2014
• Online Access: http://scholarbank.nus.edu.sg/handle/10635/94152
• Institution: National University of Singapore

10.1038/ncomms4462